Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Imunon, Inc. (IMNN : NSDQ)

• Company Description    Imunon Inc. is a fully integrated, clinical stage biotechnology company. It focused on advancing a portfolio of treatments which harness the body's natural mechanisms. The company's lead clinical program includes GEN-1. Imunon Inc., formerly known as Celsion Corporation, is based in LAWRENCEVILLE, N.J. Number of Employees: 25

• Price / Volume Information    Yesterday's Closing Price: $0.65 Daily Weekly Monthly 20 Day Moving Average: 1,203,563 shares Shares Outstanding: 17.54 (millions) Market Capitalization: $11.40 (millions) Beta: 1.93 52 Week High: $3.16 52 Week Low: $0.37 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -59.88% -61.38% 12 Week -26.97% -38.57% Year To Date -31.58% -35.92%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 997 LENOX DRIVE SUITE 100 - LAWRENCEVILLE,NJ 08648 USA ph: 609-896-9100 fax: 609-896-2200 investorrelations@imunon.com http://www.imunon.com

• General Corporate Information    Officers Stacy R. Lindborg - President and Chief Executive Officer Michael H. Tardugno - Executive Chairman David Gaiero - Chief Financial Officer Khursheed Anwer - Executive Vice President Donald P. Braun - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 15117N602 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/13/25 Share - Related Items Shares Outstanding: 17.54 Most Recent Split Date: 3.00 (0.07:1) Beta: 1.93 Market Capitalization: $11.40 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.86 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 21.02 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 46.15% vs. Previous Quarter: -21.74% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -427.98 12/31/24 - -301.82 ROA 06/30/25 - - 03/31/25 - -175.03 12/31/24 - -154.77 Current Ratio 06/30/25 - - 03/31/25 - 0.88 12/31/24 - 1.67 Quick Ratio 06/30/25 - - 03/31/25 - 0.88 12/31/24 - 1.67 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 0.03 12/31/24 - 0.29 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©